{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:43:06Z","timestamp":1784950986783,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing-Tianjin-Hebei Region of Natural Science Foundation of Tianjin","award":["22JCZXJC00140"],"award-info":[{"award-number":["22JCZXJC00140"]}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Science and technology planning project","doi-asserted-by":"crossref","award":["21ZXJBSY00110"],"award-info":[{"award-number":["21ZXJBSY00110"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tianjin Health and Science and Technology Project-Clinical Key Specialty","award":["TJWJ2024ZK001"],"award-info":[{"award-number":["TJWJ2024ZK001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"DOI":"10.1186\/s12893-025-03305-w","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:57:39Z","timestamp":1763135859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of prognostic indicators for early recurrence of gastric cancer following laparoscopic gastrectomy"],"prefix":"10.1186","volume":"25","author":[{"given":"Mingze","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengbin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2576-865X","authenticated-orcid":false,"given":"Weihua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"3","key":"3305_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"3305_CR2","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1200\/JCO.2004.10.184","volume":"22","author":"T Sano","year":"2004","unstructured":"Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy\u2013Japan clinical oncology group study 9501. J Clin Oncol. 2004;22(14):2767\u201373.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3305_CR3","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s11864-022-01004-9","volume":"23","author":"C Fong","year":"2022","unstructured":"Fong C, Johnston E, Starling N. Neoadjuvant and adjuvant therapy approaches to gastric cancer. Curr Treat Options Oncol. 2022;23(9):1247\u201368.","journal-title":"Curr Treat Options Oncol"},{"issue":"9813","key":"3305_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"Y-J Bang","year":"2012","unstructured":"Bang Y-J, Kim Y-W, Yang H-K, Chung HC, Park Y-K, Lee KH, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315\u201321.","journal-title":"Lancet"},{"issue":"2","key":"3305_CR5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s10120-016-0606-4","volume":"20","author":"N Fuse","year":"2017","unstructured":"Fuse N, Bando H, Chin K, Ito S, Yoshikawa T, Tsuburaya A, et al. Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study. Gastric Cancer. 2017;20(2):332\u201340.","journal-title":"Gastric Cancer"},{"issue":"18","key":"3305_CR6","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810\u201320.","journal-title":"N Engl J Med"},{"issue":"1","key":"3305_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11\u201320.","journal-title":"N Engl J Med"},{"issue":"13","key":"3305_CR8","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","volume":"29","author":"M Ychou","year":"2011","unstructured":"Ychou M, Boige V, Pignon J-P, Conroy T, Bouch\u00e9 O, Lebreton G, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715\u201321.","journal-title":"J Clin Oncol"},{"issue":"8","key":"3305_CR9","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S1470-2045(21)00297-7","volume":"22","author":"X Zhang","year":"2021","unstructured":"Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z, et al. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial. Lancet Oncol. 2021;22(8):1081\u201392.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3305_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cac2.12516","volume":"44","author":"F-H Wang","year":"2024","unstructured":"Wang F-H, Zhang X-T, Tang L, Wu Q, Cai M-Y, Li Y-F, et al. The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun. 2024;44(1):127\u201372.","journal-title":"Cancer Commun"},{"issue":"1","key":"3305_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72423-x","volume":"14","author":"T Yamaguchi","year":"2024","unstructured":"Yamaguchi T, Kumagai K, Yagi S, Nomura T, Nagashima K, Watanabe M, et al. Efficacy of chemotherapy for patients with gastric cancer with early recurrence during or after adjuvant chemotherapy with S-1 alone: a multicenter retrospective study. Sci Rep. 2024;14(1):21854.","journal-title":"Sci Rep"},{"issue":"2","key":"3305_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5230\/jgc.2024.24.e18","volume":"24","author":"J-Y Yang","year":"2024","unstructured":"Yang J-Y, Park J-H, Choi SJ, Lee WK. Role of recurrence pattern multiplicity in predicting post-recurrence survival in patients who underwent curative gastrectomy for gastric cancer. J Gastric Cancer. 2024;24(2):231\u201342.","journal-title":"J Gastric Cancer"},{"issue":"2","key":"3305_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.coc.0000092703.12189.a2","volume":"27","author":"B Sakar","year":"2004","unstructured":"Sakar B, Karagol H, Gumus M, Basaran M, Kaytan E, Argon A, et al. Timing of death from tumor recurrence after curative gastrectomy for gastric cancer. Am J Clin Oncol. 2004;27(2):205\u20139.","journal-title":"Am J Clin Oncol"},{"issue":"10","key":"3305_CR14","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1177\/000313481508101029","volume":"81","author":"M Alnoor","year":"2015","unstructured":"Alnoor M, Boys JA, Worrell SG, Oh DS, Hagen JA, DeMeester SR. Timing and pattern of recurrence after gastrectomy for adenocarcinoma. Am Surg. 2015;81(10):1057\u201360.","journal-title":"Am Surg"},{"issue":"15","key":"3305_CR15","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1200\/JCO.18.01138","volume":"37","author":"K Yoshida","year":"2019","unstructured":"Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, et al. Addition of docetaxel to oral fluoropyrimidine improves efficacy in patients with stage III gastric cancer: interim analysis of JACCRO GC-07, a randomized controlled trial. J Clin Oncol. 2019;37(15):1296\u2013304.","journal-title":"J Clin Oncol"},{"issue":"5","key":"3305_CR16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1007\/s10120-019-00936-w","volume":"22","author":"B-B Xu","year":"2019","unstructured":"Xu B-B, Lu J, Zheng Z-F, Xie J-W, Wang J-B, Lin J-X, et al. The predictive value of the preoperative C-reactive protein-albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial data. Gastric Cancer. 2019;22(5):1016\u201328.","journal-title":"Gastric Cancer"},{"issue":"3","key":"3305_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/jso.24370","volume":"114","author":"A-T Le","year":"2016","unstructured":"Le A-T, Tzeng C-WD. Does finding early recurrence improve outcomes, and at what cost? J Surg Oncol. 2016;114(3):329\u201335.","journal-title":"J Surg Oncol"},{"issue":"2","key":"3305_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.0260","volume":"7","author":"A Yousef","year":"2024","unstructured":"Yousef A, Yousef M, Zeineddine MA, More A, Fanaeian M, Chowdhury S, et al. Serum tumor markers and outcomes in patients with appendiceal adenocarcinoma. JAMA Netw Open. 2024;7(2):e240260.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"3305_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/SLA.0000000000001741","volume":"265","author":"G Luo","year":"2017","unstructured":"Luo G, Liu C, Guo M, Cheng H, Lu Y, Jin K, et al. Potential biomarkers in Lewis negative patients with pancreatic cancer. Ann Surg. 2017;265(4):800\u20135.","journal-title":"Ann Surg"},{"issue":"4","key":"3305_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/PL00011715","volume":"3","author":"M Kochi","year":"2000","unstructured":"Kochi M, Fujii M, Kanamori N, Kaiga T, Kawakami T, Aizaki K, et al. Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer. Gastric Cancer. 2000;3(4):177\u201386.","journal-title":"Gastric Cancer"},{"issue":"6","key":"3305_CR21","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.jhep.2023.08.020","volume":"79","author":"JS Norman","year":"2023","unstructured":"Norman JS, Li PJ, Kotwani P, Shui AM, Yao F, Mehta N. AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation. J Hepatol. 2023;79(6):1469\u201377.","journal-title":"J Hepatol"},{"key":"3305_CR22","doi-asserted-by":"crossref","unstructured":"Sawayama H, Iwatsuki M, Kuroda D, Toihata T, Uchihara T, Koga Y, Yagi T, Kiyozumi Y, Eto T, Hiyoshi Y et al. The association of the lymph node ratio and serum carbohydrate antigen 19\u2009\u2013\u20099 with early recurrence after curative gastrectomy for gastric cancer. Surg Today. 2018;48(11):994\u20131003.","DOI":"10.1007\/s00595-018-1684-1"},{"issue":"2","key":"3305_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/bjc.2015.200","volume":"113","author":"M Cummings","year":"2015","unstructured":"Cummings M, Merone L, Keeble C, Burland L, Grzelinski M, Sutton K, et al. Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival. Br J Cancer. 2015;113(2):311\u201320.","journal-title":"Br J Cancer"},{"issue":"21","key":"3305_CR24","doi-asserted-by":"publisher","first-page":"6675","DOI":"10.3748\/wjg.v21.i21.6675","volume":"21","author":"Q Pang","year":"2015","unstructured":"Pang Q, Zhang L-Q, Wang R-T, Bi J-B, Zhang J-Y, Qu K, Liu S-S, Song S-D, Xu X-S, Wang Z-X, et al. Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma. World J Gastroenterol. 2015;21(21):6675\u201383.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"3305_CR25","doi-asserted-by":"publisher","first-page":"886","DOI":"10.21037\/tlcr.2019.11.16","volume":"8","author":"H Mandaliya","year":"2019","unstructured":"Mandaliya H, Jones M, Oldmeadow C, Nordman II. Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC). Neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI). Transl Lung Cancer Res. 2019;8(6):886\u201394.","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"3305_CR26","volume":"7","author":"\u0130 Mungan","year":"2020","unstructured":"Mungan \u0130, Dicle \u00c7B, Bekta\u015f \u015e, Sar\u0131 S, Yamanyar S, \u00c7avu\u015f M, et al. Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer? Mil Med Res. 2020;7(1):9.","journal-title":"Mil Med Res"},{"issue":"2","key":"3305_CR27","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3305_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10120-018-0854-6","volume":"22","author":"J-X Lin","year":"2019","unstructured":"Lin J-X, Lin J-P, Xie J-W, Wang J-B, Lu J, Chen Q-Y, et al. Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer. Gastric Cancer. 2019;22(2):403\u201312.","journal-title":"Gastric Cancer"},{"issue":"2","key":"3305_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/jgh.14442","volume":"34","author":"K Kudou","year":"2019","unstructured":"Kudou K, Saeki H, Nakashima Y, Kamori T, Kawazoe T, Haruta Y, et al. C-reactive protein\/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer. J Gastroenterol Hepatol. 2019;34(2):355\u201363.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"3305_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-016-1076-1","volume":"15","author":"S Chen","year":"2017","unstructured":"Chen S, Nie R-C, OuYang L-Y, Li Y-F, Xiang J, Zhou Z-W, et al. Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination. World J Surg Oncol. 2017;15(1):52.","journal-title":"World J Surg Oncol"},{"issue":"8","key":"3305_CR31","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1158\/1055-9965.EPI-18-0122","volume":"27","author":"YS Park","year":"2018","unstructured":"Park YS, Park DJ, Lee Y, Park KB, Min S-H, Ahn S-H, et al. Prognostic roles of perioperative body mass index and weight loss in the long-term survival of gastric cancer patients. Cancer Epidemiol Biomarkers Prev. 2018;27(8):955\u201362.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3305_CR32","volume-title":"R: A Language and environment for statistical computing","author":"Team RC","year":"2013","unstructured":"R Core Team R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. 2024.\u00a0https:\/\/www.R-project.org\/."},{"key":"3305_CR33","unstructured":"Therneau T. A Package for Survival Analysis in R. R package version 3.8-3. 2024. https:\/\/CRAN.R-project.org\/package=survival."},{"key":"3305_CR34","unstructured":"Dayimu A. forestploter: Create a Flexible Forest Plot. R package version 1.1.2. 2024. https:\/\/CRAN.R-project.org\/package=forestploter."},{"key":"3305_CR35","unstructured":"Wickham H, Fran\u00e7ois R, Henry L, M\u00fcller K, Vaughan D. dplyr: A Grammar of Data Manipulation. R package version 1.1.4. 2023. https:\/\/CRAN.R-project.org\/package=dplyr."},{"issue":"12","key":"3305_CR36","first-page":"490","volume":"93","author":"K Seaton","year":"2001","unstructured":"Seaton K. Albumin concentration controls cancer. J Natl Med Assoc. 2001;93(12):490\u20133.","journal-title":"J Natl Med Assoc"},{"issue":"18","key":"3305_CR37","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1021\/acs.accounts.3c00309","volume":"56","author":"Y Tao","year":"2023","unstructured":"Tao Y, Jakobsson V, Chen X, Zhang J. Exploiting albumin as a versatile carrier for cancer theranostics. Acc Chem Res. 2023;56(18):2403\u201315.","journal-title":"Acc Chem Res"},{"issue":"10","key":"3305_CR38","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jtho.2017.07.022","volume":"12","author":"X Zhang","year":"2017","unstructured":"Zhang X, Liu Y, Shao H, Zheng X. Obesity paradox in lung cancer prognosis: evolving biological insights and clinical implications. J Thorac Oncol. 2017;12(10):1478\u201388.","journal-title":"J Thorac Oncol"},{"issue":"9","key":"3305_CR39","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/jamaoncol.2016.0732","volume":"2","author":"CH Kroenke","year":"2016","unstructured":"Kroenke CH, Neugebauer R, Meyerhardt J, Prado CM, Weltzien E, Kwan ML, et al. Analysis of body mass index and mortality in patients with colorectal cancer using causal diagrams. JAMA Oncol. 2016;2(9):1137\u201345.","journal-title":"JAMA Oncol"},{"issue":"12","key":"3305_CR40","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1245\/s10434-009-0645-8","volume":"16","author":"M Tokunaga","year":"2009","unstructured":"Tokunaga M, Hiki N, Fukunaga T, Ohyama S, Yamaguchi T, Nakajima T. Better 5-year survival rate following curative gastrectomy in overweight patients. Ann Surg Oncol. 2009;16(12):3245\u201351.","journal-title":"Ann Surg Oncol"},{"issue":"42","key":"3305_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001769","volume":"94","author":"H-N Chen","year":"2015","unstructured":"Chen H-N, Chen X-Z, Zhang W-H, Yang K, Chen X-L, Zhang B, et al. The impact of body mass index on the surgical outcomes of patients with gastric cancer: a 10-year, single-institution cohort study. Medicine (Baltimore). 2015;94(42):e1769.","journal-title":"Medicine (Baltimore)"},{"issue":"28","key":"3305_CR42","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.3748\/wjg.v19.i27.4596","volume":"19","author":"X-S Wu","year":"2013","unstructured":"Wu X-S, Wu W-G, Li M-L, Yang J-H, Ding Q-C, Zhang L, et al. Impact of being overweight on the surgical outcomes of patients with gastric cancer: a meta-analysis. World J Gastroenterol. 2013;19(28):4596\u2013606.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3305_CR43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000012131","volume":"59","author":"DK Dhar","year":"2000","unstructured":"Dhar DK, Kubota H, Tachibana M, Kotoh T, Tabara H, Masunaga R, et al. Body mass index determines the success of lymph node dissection and predicts the outcome of gastric carcinoma patients. Oncology. 2000;59(1):18\u201323.","journal-title":"Oncology"},{"issue":"12","key":"3305_CR44","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1054\/bjoc.2001.1720","volume":"84","author":"DH Roukos","year":"2001","unstructured":"Roukos DH, Lorenz M, Karakostas K, Paraschou P, Batsis C, Kappas AM. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study. Br J Cancer. 2001;84(12):1602\u20139.","journal-title":"Br J Cancer"},{"issue":"2","key":"3305_CR45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1046\/j.1365-2168.2000.01360.x","volume":"87","author":"CH Yoo","year":"2000","unstructured":"Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87(2):236\u201342.","journal-title":"Br J Surg"},{"issue":"9\u201310","key":"3305_CR46","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1038\/sj.bjc.6690243","volume":"79","author":"A Cuschieri","year":"1999","unstructured":"Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative group. Br J Cancer. 1999;79(9\u201310):1522\u201330.","journal-title":"Br J Cancer"},{"issue":"12","key":"3305_CR47","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1056\/NEJM199903253401202","volume":"340","author":"JJ Bonenkamp","year":"1999","unstructured":"Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, Meyer S, Plukker JT, Van Elk P, Obertop H, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340(12):908\u201314.","journal-title":"N Engl J Med"},{"issue":"3","key":"3305_CR48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000227340","volume":"51","author":"Y Maehara","year":"1994","unstructured":"Maehara Y, Kusumoto T, Takahashi I, Kakeji Y, Baba H, Akazawa K, et al. Predictive value of preoperative carcinoembryonic antigen levels for the prognosis of patients with well-differentiated gastric cancer. A multivariate analysis. Oncology. 1994;51(3):234\u20137.","journal-title":"Oncology"},{"issue":"6","key":"3305_CR49","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1159\/000227515","volume":"52","author":"Y Ikeda","year":"1995","unstructured":"Ikeda Y, Oomori H, Koyanagi N, Mori M, Kamakura T, Minagawa S, et al. Prognostic value of combination assays for CEA and CA 19\u2009\u2013\u20099 in gastric cancer. Oncology. 1995;52(6):483\u20136.","journal-title":"Oncology"},{"issue":"4","key":"3305_CR50","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/jjco\/hyad189","volume":"54","author":"S Yagi","year":"2024","unstructured":"Yagi S, Kumagai K, Nunobe S, Ishizuka N, Yamaguchi T, Imai Y, et al. Risk factors for early recurrence after radical gastrectomy followed by adjuvant chemotherapy for stage II or III gastric cancer: a multicenter, retrospective study. Jpn J Clin Oncol. 2024;54(4):403\u201315.","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"3305_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-022-01667-z","volume":"22","author":"C Shibata","year":"2022","unstructured":"Shibata C, Nakano T, Yasumoto A, Mitamura A, Sawada K, Ogawa H, et al. Comparison of CEA and CA19-9 as a predictive factor for recurrence after curative gastrectomy in gastric cancer. BMC Surg. 2022;22(1):213.","journal-title":"BMC Surg"},{"issue":"1","key":"3305_CR52","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.amjsurg.2016.05.012","volume":"213","author":"Y Toiyama","year":"2017","unstructured":"Toiyama Y, Yasuda H, Ohi M, Yoshiyama S, Araki T, Tanaka K, et al. Clinical impact of preoperative albumin to globulin ratio in gastric cancer patients with curative intent. Am J Surg. 2017;213(1):120\u20136.","journal-title":"Am J Surg"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03305-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-025-03305-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03305-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:03:41Z","timestamp":1763136221000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-025-03305-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3305"],"URL":"https:\/\/doi.org\/10.1186\/s12893-025-03305-w","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Ethical Committee of Tianjin Medical University General Hospital (NO. IRB2024-YX-469-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The requirement for written informed consent was waived by the Ethical Committee of Tianjin Medical University General Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"541"}}